(1992). Patent Update: Angiotensin-II Antagonists: Patent Activity since the Discovery of DuP-753. Current Opinion on Therapeutic Patents: Vol. 2, No. 10, pp. 1693-1718.
36 citations
Cite
SaveGo to paper →
Taylor & Francis
Current Opinion on Therapeutic Patents Template
Write in a clean editor, then format for Current Opinion on Therapeutic Patents in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Current Opinion on Therapeutic Patents format
Current Opinion on Therapeutic Patents is a peer-reviewed journal published by Taylor & Francis, covering Monoclonal and Polyclonal Antibodies Research, Synthesis and Biological Evaluation, Synthesis and Reactions of Organic Compounds.
| Publisher | Taylor & Francis |
|---|---|
| Reference style | Author–year (Chicago, T&F) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Current Opinion on Therapeutic Patents 12 (3): 45–58.
Formats any DOI in Current Opinion on Therapeutic Patents style. No sign-up. |
| Publishes research in | Monoclonal and Polyclonal Antibodies Research Synthesis and Biological Evaluation Synthesis and Reactions of Organic Compounds HIV/AIDS drug development and treatment Cholinesterase and Neurodegenerative Diseases |
| ISSN | 0962-2594 |
| h-index | 7 |
| i10-index | 7 |
| Total citations | 393 |
| Top institutions publishing here | United States Military Academy |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Current Opinion on Therapeutic Patents per year
Citation impact of Current Opinion on Therapeutic Patents by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Current Opinion on Therapeutic Patents
(1992). Overview: PAF Receptor Antagonists: Recent Advances. Current Opinion on Therapeutic Patents: Vol. 2, No. 5, pp. 583-623.
25 citations
Cite
SaveGo to paper →
21 citations
Cite
SaveGo to paper →
20 citations
Cite
SaveGo to paper →
17 citations
Cite
SaveGo to paper →
Related journal templates
Behaviour & Information Technology
Cartography and Geographic Information Science
Combustion Science and Technology
Combustion Theory and Modelling
Communications in Algebra
Communications in Partial Differential Equations
Communications in Statistics - Simulation and Computation
Communications in Statistics - Theory and Methods
Current Opinion on Therapeutic Patents template — frequently asked questions
How do I write a paper in the Current Opinion on Therapeutic Patents format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Current Opinion on Therapeutic Patents template. When you export, DocuGuru compiles the paper into the official Taylor & Francis format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Current Opinion on Therapeutic Patents use?
Current Opinion on Therapeutic Patents uses Author–year (Chicago, T&F) references, shown as author–year markers such as (Smith, 2023) in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Current Opinion on Therapeutic Patents 12 (3): 45–58.
Do I need to know LaTeX to submit to Current Opinion on Therapeutic Patents?
No. DocuGuru generates the interact LaTeX class and compiles the PDF for you in the background, so you get a Taylor & Francis-ready Current Opinion on Therapeutic Patents document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Current Opinion on Therapeutic Patents template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Current Opinion on Therapeutic Patents format with correct headings, figures, tables, and author–year citations.
Who publishes Current Opinion on Therapeutic Patents?
Current Opinion on Therapeutic Patents is a multidisciplinary journal published by Taylor & Francis. DocuGuru's Current Opinion on Therapeutic Patents template matches Taylor & Francis's official submission format.
Can I export a submission-ready Current Opinion on Therapeutic Patents PDF?
Yes — DocuGuru produces a PDF built with the official Current Opinion on Therapeutic Patents template (the interact class) that is ready to submit to Taylor & Francis, together with the matching LaTeX source files.
How much does the Current Opinion on Therapeutic Patents template cost?
You can start writing in the Current Opinion on Therapeutic Patents template for free. Exporting the final submission-ready Current Opinion on Therapeutic Patents PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.